About
Impulse Dynamics is a medical technology company that develops innovative cardiac therapies to improve the lives of patients suffering from heart failure. The company is headquartered in Mount Laurel, New Jersey, and has a global presence with operations in Europe, Asia, and the Middle East.
The company’s flagship product is the Optimizer Smart System, which is an implantable device that delivers Cardiac Contractility Modulation (CCM) therapy. CCM therapy works by delivering electrical signals to the heart during the relaxation phase of the cardiac cycle, improving the strength and efficiency of the heart muscle. The device is designed to be implanted just under the skin in the upper chest area and connected to the heart via wires. The device is about the size of a small smartphone and is battery-powered.
The Optimizer Smart System is the only CCM device approved by the FDA for the treatment of moderate to severe heart failure. The device has been shown to improve exercise capacity, quality of life, and functional status in heart failure patients. The therapy has also been shown to be safe and effective in patients with reduced ejection fraction (EF) who remain symptomatic despite optimal medical therapy.
Impulse Dynamics Medical Devices
1 – Optimizer Smart System
The Optimizer Smart System is an implantable medical device developed by Impulse Dynamics for the treatment of heart failure. The device delivers Cardiac Contractility Modulation (CCM) therapy, which involves the delivery of electrical signals to the heart during the relaxation phase of the cardiac cycle.
The device is about the size of a small smartphone and is implanted just under the skin in the upper chest area. It is connected to the heart via wires and is battery-powered. The device is designed to improve the strength and efficiency of the heart muscle, thereby improving exercise capacity, quality of life, and functional status in heart failure patients.
In clinical studies, the Optimizer Smart System has demonstrated significant improvements in exercise capacity, quality of life, and functional status, as well as a reduction in hospitalizations for heart failure. The device has the potential to improve the lives of millions of heart failure patients worldwide.
